Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,010 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
Mulder BJ, van der Doef RM, van der Wall EE, Tijssen JG, Piek JJ, van der Meer J, Dunning AJ. Mulder BJ, et al. Among authors: van der doef rm, van der wall ee, van der meer j. Eur Heart J. 1994 Aug;15(8):1129-34. doi: 10.1093/oxfordjournals.eurheartj.a060639. Eur Heart J. 1994. PMID: 7988607 Clinical Trial.
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, Kootstra GJ, Ascoop CA, Mulder BJ, Pfisterer M, van Gilst WH, Lie KI. van der Meer J, et al. Among authors: van gilst wh. Lancet. 1993 Jul 31;342(8866):257-64. doi: 10.1016/0140-6736(93)91815-4. Lancet. 1993. PMID: 8101300 Clinical Trial.
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
van der Meer J, Brutel de la Rivière A, van Gilst WH, Hillege HL, Pfisterer M, Kootstra GJ, Dunselman PH, Mulder BJ, Lie KI. van der Meer J, et al. Among authors: van gilst wh. J Am Coll Cardiol. 1994 Nov 1;24(5):1181-8. doi: 10.1016/0735-1097(94)90096-5. J Am Coll Cardiol. 1994. PMID: 7930237 Free article. Clinical Trial.
Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. CABADAS. Research Group of the Interuniversity Cardiology Institute of The Netherlands. Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole and Acenocoumarol/phenoprocoumon Study.
Tan ES, van der Meer J, Jan de Kam P, Dunselman PH, Mulder BJ, Ascoop CA, Pfisterer M, Lie KI. Tan ES, et al. Among authors: van der meer j. J Am Coll Cardiol. 1999 Nov 15;34(6):1760-8. doi: 10.1016/s0735-1097(99)00404-0. J Am Coll Cardiol. 1999. PMID: 10577567 Free article.
Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, Dunselman PH, Mulder BJ, Michels HR, Buser PT, van Gilst WH, Lie KI. van der Meer J, et al. Among authors: van gilst wh. Thromb Haemost. 1994 Nov;72(5):676-81. Thromb Haemost. 1994. PMID: 7900073
A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, van Gilst WH, Brutel de la Rivière A, Dunselman PH, Fidler V, Kootstra GJ, Mulder BJ, Pfisterer M, Lie KI. van der Meer J, et al. Among authors: van gilst wh. Circulation. 1994 Nov;90(5):2367-74. doi: 10.1161/01.cir.90.5.2367. Circulation. 1994. PMID: 7955195 Clinical Trial.
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
Veeger NJ, Piersma-Wichers M, Tijssen JG, Hillege HL, van der Meer J. Veeger NJ, et al. Among authors: van der meer j. Br J Haematol. 2005 Feb;128(4):513-9. doi: 10.1111/j.1365-2141.2004.05348.x. Br J Haematol. 2005. PMID: 15686461 Free article.
Logistical problems in prehospital thrombolysis.
Brügemann J, van der Meer J, de Graeff PA, Takens LH, Lie KI. Brügemann J, et al. Among authors: van der meer j. Eur Heart J. 1992 Jun;13(6):787-8. doi: 10.1093/oxfordjournals.eurheartj.a060257. Eur Heart J. 1992. PMID: 1623868 Clinical Trial.
2,010 results